The NRG Oncology clinical trial NRG-RTOG 1010, studying the addition of the drug trastuzumab to chemoradiation and surgery, did not reach its primary goal of improving disease-free survival (DFS) rates for patients with HER2 ...
Jan 21, 2022
0
15
Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a ...
Aug 13, 2021
0
288
The first thing to know is: The COVID vaccines are safe, effective, and necessary. Doctors recommend them and the vaccines are available to everyone ages 12 and older in New York state.
Jun 8, 2021
0
7
New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues as to why they experienced a high death rate of 33% when the coronavirus swept across Europe.
Jun 16, 2020
0
1
In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis ...
Nov 12, 2018
0
0
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...
Aug 30, 2018
0
3
Two drugs that target different mutations showed encouraging results in treating leukemia, according to recent clinical trials published in the New England Journal of Medicine (NEJM) and The Lancet Oncology.
Jul 10, 2018
0
17
It is possible to have breaks in long-term medication against hormone-sensitive breast cancer without influencing the effect of the treatment. Women also feel better if they take a three-month break from the hormone treatment ...
Dec 1, 2017
0
2
Thousands of breast cancer patients at risk of developing aggressive secondary tumours could benefit from a potential new genetic test.
Oct 25, 2017
0
8
Emeritus Professor Sheila Payne from the International Observatory on End of Life Care at Lancaster University helped conduct the study commissioned by the European Association for Palliative Care (EAPC) and published in ...
Sep 5, 2017
0
1
